Lancet Global Health

Article	Citations
Financial incentives for reduced alcohol use and increased isoniazid adherence during tuberculosis preventive therapy among people with HIV in Uganda: an open-label, factorial randomised controlled tr	1325
Bringing home manufacturing of medical products	731
Racism and health: the need for urgent action	506
Periconceptional diet and the risk of gestational diabetes in south Indian women: findings from the BAngalore Nutrition Gestational diabetes LiFEstyle Study (BANGLES)	453
Queering global health: a feminist and lesbian, gay, and bisexual perspective – Authors' reply	433
The cause of nodding syndrome remains unknown	422
C-reactive protein: another addition to our armamentarium against tuberculosis?	341
Is now the time for revisiting supplements for pregnant women?	321
Effectiveness and safety of fexinidazole for gambiense human African trypanosomiasis and exploration of adherence in outpatients: a phase 3b, prospective, open-label, non-randomised, cohort study	274
The road to malaria elimination: why a robust surveillance system is imperative	274
Prenatal exposure to HIV pre-exposure prophylaxis and birth, growth, and social–emotional developmental outcomes throughout early childhood in Kenya: a prospective cohort study	259
Enhancing global cancer care for sexual and gender minority populations: regional perspectives and global implications	244
Correction to Lancet Glob Health 2024; published online Sept 23. https://doi.org/10.1016/S2214-109X(24)00320-6	224
Automated oxygen control for preterm infants receiving continuous positive airway pressure in southwest Nigeria: an open-label, randomised, crossover trial	221
Influenza vaccination in failing hearts	219
Performance of standardised colposcopy to detect cervical precancer and cancer for triage of women testing positive for human papillomavirus: results from the ESTAMPA multicentric screening study	211
Implementation of the 7-1-7 target for detection, notification, and response to public health threats in five countries: a retrospective, observational study	209
Patient-level and system-level determinants of stroke fatality across 16 large hospitals in Ghana and Nigeria: a prospective cohort study	205
Indonesia's first nationwide health screening programme	200
Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income cou	195
Safe scale-up of simulation-based training for minimally invasive surgery	193
Rwanda’s lessons for strengthening Africa’s response to current Marburg virus disease outbreaks	191
Potential benefit of extended dose schedules of human papillomavirus vaccination in the context of scarce resources and COVID-19 disruptions in low-income and middle-income countries: a mathematical m	185
Comparison of maternal and neonatal outcomes of COVID-19 before and after SARS-CoV-2 omicron emergence in maternity facilities in Malawi (MATSurvey): data from a national maternal surveillance platfor	184
The pneumonia challenge: time to end the global neglect	178

Outcomes of rheumatic fever in Uganda: a prospective cohort study	169
Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study	161
Assessing the prevalence and impact of preserved ratio impaired spirometry in low-income and middle-income countries: a post-hoc cross-sectional analysis	157
Global patterns and trends in Kaposi sarcoma incidence: a population-based study	147
The health status of Indonesia's provinces: the double burden of diseases and inequality gap	142
The state of health in Pakistan and its provinces and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019	139
The future of the International Health Regulations	135
Physical inactivity: another casualty of climate change	134
Bridging the gap: why Africa must invest in AI infrastructure for health care	129
Mortality in patients admitted to hospital with heart failure in China: a nationwide Cardiovascular Association Database-Heart Failure Centre Registry cohort study	128
Mpox vaccination strategies in DR Congo	126
Expanding access to long-acting HIV therapy in low-income and middle-income countries	123
Resolving the CD4-testing crisis to help end AIDS-related deaths	120
Human papillomavirus vaccine effect against human papillomavirus infection in Rwanda: evidence from repeated cross-sectional cervical-cell-based surveys	120
The cost of inaction on physical inactivity to public health-care systems: a population-attributable fraction analysis	116
The drug drought in maternal health: an ongoing predicament	107
Intravenous versus oral iron for anaemia among pregnant women in Nigeria (IVON): an open-label, randomised controlled trial	107
Using verbal autopsy to enhance mortality surveillance	106
Effectiveness and cost-effectiveness of a stepped care framework for psychological interventions for reducing common mental health symptoms in Jordan: a single-blind randomised clinical trial	106
Payment in arrears: a global health inequity that must be corrected	105
Mathematical modelling to accurately quantify the benefits of pneumococcal conjugate vaccine	105
Lessons for future implementation of the E-MOTIVE bundle	103
Experiences of an Israeli hospital in the management of repatriated civilian hostages	100
Advancing maternal and perinatal health through clinical trials: key insights from a WHO global consultation	99
Infertility—why the silence?	99
Cost-effectiveness and health impact of screening and treatment of Mycobacterium tuberculosis infection among formerly incarcerated individuals in Brazil: a Markov modelling study	97
Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026	90
COVID-19 in the 47 countries of the WHO African region: a modelling analysis of past trends and future patterns	90
Using theory to understand how interventions work and inform future implementation	90
Correction to Lancet Glob Health 2026; published online March 11 https://doi.org/10.1016/S2214-109X(25)00534-0	89
Changes in incidence of HPV-related cancers in South Africa (2011–21): a cross-sectional analysis of the South African National Cancer Registry	89
Understanding deaths from diarrhoea in children younger than 5 years	88
Pregnancy in people who have survived Ebola virus disease	88
Mpox: evidence for strengthening and sustaining global surveillance	87
How to DREAMM and end HIV-related deaths	85
Addressing the social inequities of vaccination: an imperative to close the gap	83
Locally validated biomarker cutoffs should inform micronutrient deficiency burdens – Authors' reply	82
Cervical cancer elimination: actions needed in the COVID-19 era	81
Sustainability of a 12-month lifestyle intervention delivered by community health workers in reducing blood pressure in Nepal: 5-year follow-up of the COBIN open-label, cluster randomised trial	81
Catastrophic health expenditure during the COVID-19 pandemic in five countries: a time-series analysis	81
WHO model list of essential in vitro diagnostics: strengthening diagnostics capacity to transform health care for all	79
Climate change and health: the next challenge of ethical AI	78
The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review	78
Pregnancy, pregnancy outcomes, and infant growth and development after recovery from Ebola virus disease in Liberia: an observational cohort study	76
A call for an Africa-centric health research ethics framework: a way forward for shaping global health research	76
Introduction and rollout of malaria vaccines in Cameroon and Burkina Faso: early lessons learned	74
Routine immunisation coverage in the context of seasonal influenza vaccine introduction for children in Nakuru and Mombasa counties in Kenya, 2019–21: an observational study	73
Correction to Lancet Glob Health 2022; 10: e1443–52	72
Correction to Lancet Glob Health 2023; 11: e1978–85	70
Correction to Lancet Glob Health 2025; 13: e2013–26	69

Correction to Lancet Glob Health 2015; 3: e196	69
Improving access to liposomal amphotericin B worldwide	67
Uncertainty in key population size estimates in sub-Saharan Africa	67
Highlighting the need for investment and innovation in ART retention interventions	66
Avoidable deaths through the primary prevention, early detection, and curative treatment of cancer worldwide: a population-based study	65
Reducing global inequities in medical oxygen access: the Lancet Global Health Commission on medical oxygen security	64
TAK-003 dengue vaccine as a new tool to mitigate dengue in countries with a high disease burden	63
Switching antibiotic therapy from injectable to oral to optimise the duration of inpatient care for young infants presenting with moderate-mortality-risk signs of possible serious bacterial infection:	63
Quality of inpatient paediatric and newborn care in district hospitals: WHO indicators, measurement, and improvement	62
Beyond malaria: can intermittent preventive treatment with sulphadoxine-pyrimethamine reduce the number of small vulnerable newborns globally?	62
Innovative blood transfusion strategies to address global blood deserts: a consensus statement from the Blood Delivery via Emerging Strategies for Emergency Remote Transfusion (Blood DESERT) Coalition	61
Aedes albopictus invasion across Africa: the time is now for cross-country collaboration and control	61
Global, regional, and national health-care inefficiency and associated factors in 201 countries, 1995–2022: a stochastic frontier meta-analysis for the Global Burden of Disease Study 2023	61
Advancing functional and systemic integration of HIV prevention into public health systems	60
Every baby counts: eliminating all preventable child deaths	60
Characterisation of febrile non-traumatic coma in sub-Saharan Africa	60
Equity challenges in Indonesian health care	59
A home away from home? HIV outcomes among refugees and host country nationals	59
Low risk, high impact: the hidden burden of cardiovascular disease	58
COVID-19 in pregnancy: evidence from LMICs	58
People who inject drugs in the Eastern Mediterranean region	57
Correction to Lancet Glob Health 2022; 10: e1115–27	57
Lots of considerations when evaluating the FujiLAM assay – Author's reply	57
Migrants and displaced people: intentionally endangered and inconsistently visible	57
Hepatitis E vaccination: continued benefit for pregnant women in vulnerable settings	56
AI for health or AI for war? Challenging the military partnerships behind climate harm	56
Characteristics, management, and outcomes in women and men with congestive heart failure in 40 countries at different economic levels: an analysis from the Global Congestive Heart Failure (G-CHF) regi	55
Respiratory syncytial virus infection among children younger than 2 years admitted to a paediatric intensive care unit with extended severe acute respiratory infection in ten Gavi-eligible countries:	55
Potassium-enriched salt substitutes: supporting global cardiovascular and kidney health	54
Reducing antibiotic use with diarrhoeal vaccines	53
Precision in prescription: multiple micronutrient supplements in pregnancy	53
Maternal intimate partner violence and child health outcomes	53
Identifying gaps in the HIV treatment cascade in Africa: a model comparison study	52
Addressing global micronutrient inadequacies: enhancing global data representation	52
Pulse oximetry to detect paediatric hypoxaemia—the fifth vital sign	51
The impact of ivermectin, diethylcarbamazine citrate, and albendazole mass drug administration on the prevalence of scabies and soil-transmitted helminths in school-aged children in three municipaliti	51
Unveiling the crisis of the double burden of malnutrition	51
Reopening the humanitarian corridor from Gaza to the West Bank and East Jerusalem for medical evacuations	51
Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Le	50
Live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b–2a, double-blind, dose-escalation, randomised controlled t	49
Diagnostic yield of urine lipoarabinomannan and sputum tuberculosis tests in people living with HIV: a systematic review and meta-analysis of individual participant data	49
Ranking the most efficient human papillomavirus vaccination strategies in low-income and lower-middle income countries: a mathematical modelling analysis	49
Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis	48
Implementation strategies to build mental health-care capacity in Malawi: a health-economic evaluation	48
Tuberculosis and undernutrition in India – Authors’ reply	47
The landscape for rare diseases in 2024	47
Donor aid and research funding for newborn babies and preventing stillbirths	47
Can the ShangRing bring us closer to endorsing early infant male circumcision in sub-Saharan Africa?	46
More treatment options for rifampicin-resistant tuberculosis: the role of economic evaluation in informing uptake	46
Cost-effectiveness of the expansion of PrEP for HIV infection in the Asia Pacific region	45
Can resistance testing improve outcomes for children and adolescents with HIV?	45
Correction to Lancet Glob Health 2024; 12: e1389–90	45
The challenge of promoting physical activity in low-income and middle-income countries	44
Avoiding another lost decade in reducing malaria burden in African infants and young children	43
Maximising human health and development through synergistic partnerships: the African Biobank and Longitudinal Epidemiological Ecosystem	43
Universal health coverage is fundamental to preparing for a healthier and better tomorrow	43
Beyond measuring coverage: how timeliness could transform routine childhood vaccination programmes	42
How the EAT–Lancet Commission on food in the Anthropocene influenced discourse and research on food systems: a systematic review covering the first 2 years post-publication	42
Diagnostic innovations to find the missing millions with tuberculosis	41
Estimating the cost of achieving basic water, sanitation, hygiene, and waste management services in public health-care facilities in the 46 UN designated least-developed countries: a modelling study	41
Innovative methods of determining health expenditure efficiency are urgently needed	41
Clinical characteristics and outcomes of patients with cirrhosis and hepatocellular carcinoma in The Gambia, west Africa: a prospective cohort study	40
Predicting mortality within 1 year of ART initiation in children and adolescents living with HIV in sub-Saharan Africa: a retrospective observational cohort study	40
Incidence of and risk factors for small vulnerable newborns in north India: a secondary analysis of a prospective pregnancy cohort	40
The effect of tranexamic acid during childbirth on maternal mortality: an epidemiological modelling and cost-effectiveness study	40
Policy and service delivery proposals to improve primary care services in low-income and middle-income country cities	40
Prices, availability, and affordability of adult medicines in 54 low-income and middle-income countries: evidence based on a secondary analysis	40
Nutritional support for adult patients with microbiologically confirmed pulmonary tuberculosis: outcomes in a programmatic cohort nested within the RATIONS trial in Jharkhand, India	39
The Global Retinoblastoma Outcome Study: a prospective, cluster-based analysis of 4064 patients from 149 countries	39
Clinical and regulatory development strategies for Shigella vaccines intended for children younger than 5 years in low-income and middle-income countries	39
Quartile-based risk exposure in global IHD and ischaemic stroke	39
HIV testing during systematic screening for tuberculosis among household contacts in high-tuberculosis burden settings: a systematic review and meta-analysis	38
Infant-level and child-level predictors of mortality in low-resource settings: the WHO Child Mortality Risk Stratification Multi-Country Pooled Cohort	38
Geospatial disparities in survival of patients with breast cancer in sub-Saharan Africa from the African Breast Cancer-Disparities in Outcomes cohort (ABC-DO): a prospective cohort study	38
Wastewater monitoring can anchor global disease surveillance systems	38
Finding balance in Nigeria's mandatory health insurance	37
Nodding syndrome and doxycycline: promising findings with open questions	37
Prevention of pneumococcal diseases: the challenge remains	37
The role of digital health and artificial intelligence in improving the reach and effectiveness of HIV prevention in Africa	37
Combating antimicrobial resistance in neonatal infections: a South African perspective	37

Colorectal cancer screening with fecal immunochemical testing in Nigeria – Authors' reply	37
Correction to Lancet Glob Health 2025; 13: e309–18	36
Balancing global access to opioids	36
Correction to Lancet Glob Health 2022; 10: 1715–43	36
Implementation science in Africa—whose epistemology counts?	36
Correction to Lancet Glob Health 2025; 13: e528–84	36
Integrating mental health care to reduce intimate partner violence in complex humanitarian emergencies	35
Policy to progress: embedding enforcement in Asian NCCPs	35
The need for a One Health approach for influenza surveillance	35
Navigating AMR with innovative diagnostics	35
Variability and social patterning of cancer mortality in 343 Latin American cities: an ecological study	35
Defining the usefulness of oral swabs in tuberculosis diagnosis	35
Postnatal morbidity: prevalent, enduring, and neglected	34
Catastrophic health expenditure and chronic respiratory disease: evidence from Kenya	34
National diabetes prevention programmes in LMICs are now a necessity	34
Neonatal mortality during the war in Tigray: a cross-sectional community-based study	34
The effect on HIV transmission and cost-effectiveness of programmes for female sex workers in East, Central, and Southern Africa: a modelling study	34
The challenging road to universal health coverage	34
Mpox vaccination strategies in DR Congo	34
Pragmatic global health	33
Relapse after recovery from acute malnutrition	33
The need for epidemiological data on HIV-related CNS infections in low-income and middle-income settings	33
The effect of a social network-based intervention to promote HIV testing and linkage to HIV services among fishermen in Kenya: a cluster-randomised trial	33
Distinguishing between mortality rates for heart failure with preserved versus reduced ejection fraction – Authors' reply	33
Targeting malaria control to schoolchildren	33
The health toll of economic sanctions	33
The continuum of menstrual health through the life course	33
Individual-level and community-level factors for 10-year cardiovascular disease risk in Ethiopia: a retrospective, population-based, cross-sectional, observational study	33
Urgent call for the prioritisation of palliative care in Syria	32
Colorectal cancer screening in sub-Saharan Africa	32
Global radiotherapy demands and corresponding radiotherapy-professional workforce requirements in 2022 and predicted to 2050: a population-based study	32
Evaluation of a face-washing behaviour change intervention for trachoma prevention in Oromia, Ethiopia (Stronger SAFE): secondary outcomes of a cluster-randomised controlled trial	32
Diagnostic yield as an important metric for the evaluation of novel tuberculosis tests: rationale and guidance for future research	32
Aminoglycosides, deafness, and non-tuberculous mycobacteria	32
Human versus equine intramuscular antitoxin, with or without human intrathecal antitoxin, for the treatment of adults with tetanus: a 2 × 2 factorial randomised controlled trial	32
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial	31
The potential impact of reductions in international donor funding on tuberculosis in low-income and middle-income countries: a modelling study	31
Global, regional, and national causes of death in children and adolescents younger than 20 years: an open data portal with estimates for 2000–21	31
Enhancing cervical and breast cancer training in Africa with e-learning	31
Methods with consequences: analysing demographic diversity in global health governance and knowledge production	31
Scarcity of research on breastfeeding and Ebola diseases is placing the lives of women and infants at risk: a call to specific action	31
Primary care institutional characteristics associated with hypertension awareness, treatment, and control in the China PEACE-Million Persons Project and primary health-care survey: a cross-sectional s	31
Strengthening health-care systems to reduce child mortality	31
Prediabetes: the best opportunity to reach remission	30
Indigenous and minority groups in diabetes trials	30
Correction to Lancet Glob Health 2024; 12: e25–27	30
Obstetric fistula in Bangladesh: estimates from a national survey with clinical validation correction	30
Evolving crises and unprecedented need: research on health in humanitarian settings must not be overlooked	30
Countries cannot cover the shortfall from US funding cuts	30
Correction to Lancet Glob Health 2024; 12: e1209–13	30
Peripheral artery disease: a global need for detection, prevention, and treatment	30
Monitoring the benefits of human papillomavirus vaccination in low-income and middle-income countries	30
Measuring cause of death in rural southeast Asia	30
Nigeria's mandatory health insurance and the march towards universal health coverage	30
Understanding the WHO global strategy to accelerate cervical cancer elimination – Authors' reply	29
Socioeconomic inequalities in palliative care access: insights from SHARE	29
(Re-) considering success in implementation science: experiences amid a co-designed mHealth intervention in rural Uganda	29
Bridging the divide between religion and health care	29
Mind the gap: rethinking global alcohol metrics in high-abstention low-income and middle-income countries	29
What can we learn from developments in primary health care in south Asia?	29
Cost-effectiveness of intervention combinations towards the elimination of vertical transmission of HIV in limited-resource settings: a mathematical modelling study	29
Maximising the value of nudge units for global health	29
Recognising type 5 diabetes – Authors' reply	29
Scaling an intervention for the engagement of people with HIV who inject drugs into care in Viet Nam: an implementation-effectiveness, cluster-randomised trial	28
Democratising clinical trials research to strengthen primary health care	28
Research priorities for data science and artificial intelligence in global health: an international consensus exercise	28
Postpartum maternal and infant haematological effects of second-trimester ferric carboxymaltose versus standard-of-care oral iron in Malawi: longitudinal follow-up of a randomised controlled trial	28
Community interventions to prevent violence against women and girls in informal settlements in Mumbai: a theory-driven, pragmatic, cluster-randomised, controlled trial	28
Effectiveness of a new vaccine for outbreak response and the increasingly complicated polio endgame	28
Effectiveness of the RTS,S/AS01E malaria vaccine in a real-world setting over 1 year of follow-up after the three-dose primary schedule: an interim analysis of a phase 4 study in Ghana, Kenya, and Mal	28
Transmission reduction, health benefits, and upper-bound costs of interventions to improve retention on antiretroviral therapy: a combined analysis of three mathematical models	28
The use of imagery in global health: an analysis of infectious disease documents and a framework to guide practice	28
Current testing systems are a barrier to achieving the 7-1-7 target for detection, notification, and response to public health threats	28
Prevalence of all epilepsies in urban informal settlements in Nairobi, Kenya: a two-stage population-based study	27
Research ethics systems in Latin America and the Caribbean: a systemic assessment using indicators	27
The aetiology and prevalence of preoperative anaemia in patients undergoing major surgery (ALICE): an international, prospective, observational cohort study	27
Population size, HIV prevalence, and antiretroviral therapy coverage among key populations in sub-Saharan Africa: collation and synthesis of survey data, 2010–23	27
Short-term aid or long-term gains? Harnessing Sudan's humanitarian response for the resilience of its health system	27
A call to action: the global failure to effectively tackle maternal mortality rates	27
Antimicrobial resistance and the great divide: inequity in priorities and agendas between the Global North and the Global South threatens global mitigation of antimicrobial resistance	27
Prevalence and changes of intimate partner violence against women aged 15 to 49 years in 53 low-income and middle-income countries from 2000 to 2021: a secondary analysis of population-based surveys	27
Redefining implementation science for global health decolonisation	26
Mpox outbreaks in Africa constitute a public health emergency of continental security	26
Prevalence of diabetic retinopathy in India stratified by known and undiagnosed diabetes, urban–rural locations, and socioeconomic indices: results from the SMART India population-based cross-sectiona	26
Clinical impact and cost-effectiveness of the WHO-recommended advanced HIV disease package of care	26
Estimating dementia prevalence using remote diagnoses and algorithmic modelling: a population-based study of a rural region in South Africa	26
Global climate justice and the future of air quality co-benefits in low-income and middle-income countries: an energy, climate, and health modelling study	26
Malaria guidelines fall short in diagnosing acute kidney injury	26
The global economic burden of chronic obstructive pulmonary disease for 204 countries and territories in 2020–50: a health-augmented macroeconomic modelling study	26
Prevalence, awareness, treatment, and control of diabetes in India: a nationally representative survey of adults aged 45 years and older	26
A successful UN High-Level Meeting on antimicrobial resistance must build on the 2023 UN High-Level Meeting on tuberculosis	25
Poliovirus antibodies following two rounds of campaigns with a type 2 novel oral poliovirus vaccine in Liberia: a clustered, population-based seroprevalence survey	25
Cybersecurity in the age of digital pandemics: protecting patient data in low-income and middle-income countries	25
Assessment of serological responses following vaccination campaigns with type 2 novel oral polio vaccine: a population-based study in Tajikistan in 2021	25
Addressing the adherence challenge in tuberculosis treatment: more than digital technologies	25